Apex Laboratory Editorial Team

The Apex Laboratory Editorial Team — our internal research coordinators, quality control staff, and content editors — is responsible for every guide in the Research Library. All content is verified against primary peer-reviewed literature under our four-stage review process. Read our full editorial standards at https://apexlaboratory.org/editorial-standards/

Sermorelin GHRH 1-29 research-grade peptide: synthetic 29-amino-acid GHRH receptor agonist for in-vitro and preclinical research, with historical Geref pharmaceutical formulation context

Sermorelin Research Guide

Sermorelin Research Guide: GHRH 1-29 Mechanism, Geref® FDA History & Research Applications Quick Answer Sermorelin is a synthetic 29-amino-acid peptide, the minimal receptor-active N-terminal fragment (GHRH 1-29) of the parent 44-residue human growth hormone-releasing hormone characterized at the Salk Institute in 1982. It acts as a selective agonist of the GHRH receptor (GHRHR) on anterior

Sermorelin Research Guide Read More »

Stylized molecular structure of Semaglutide, a GLP-1 receptor agonist peptide, rendered as a 3D research illustration on a slate-teal background.

Semaglutide Research Guide

Semaglutide is a 31-residue acylated GLP-1 receptor agonist studied for its effects on glucose regulation, body composition, and cardiovascular outcomes. Its long-chain fatty-acid albumin-binding tether extends plasma half-life to roughly seven days, enabling once-weekly dosing in research and clinical contexts. Trial evidence comes from the SUSTAIN, STEP, PIONEER, and SELECT programs — one of the

Semaglutide Research Guide Read More »

Epithalon telomerase activating peptide with DNA telomere visualization — longevity research — Apex Laboratory

Epithalon (Epitalon): Telomerase Research & the Khavinson Peptides

Comprehensive research guide to Epithalon (Epitalon), the tetrapeptide telomerase activator from the Khavinson bioregulator peptide program. CAS 307297-39-8, MW 390.35 g/mol. Telomerase mechanism, pineal gland regulation, published longevity studies, and connection to the broader Khavinson peptide family.

Epithalon (Epitalon): Telomerase Research & the Khavinson Peptides Read More »

Retatrutide triple receptor agonist research peptide — GIP GLP-1 glucagon mechanism — Apex Laboratory

Retatrutide: The Triple Agonist Peptide — Mechanism, Phase 2 Data & Research Applications

Comprehensive guide to Retatrutide (LY3437943), the first-in-class GIP/GLP-1/glucagon triple receptor agonist. CAS 2381089-83-2, MW 4471.5 g/mol. Triple agonist mechanism, Phase 2 NEJM data, comparison to Tirzepatide and Semaglutide, and research significance.

Retatrutide: The Triple Agonist Peptide — Mechanism, Phase 2 Data & Research Applications Read More »

Shopping Cart